US$ 29.30
pep pt141 PT-141 PT-141 - Injectable Peptide
Description
331344, doi:10.1016/j.jsmc.2017.03.009

Edited by: Dolan J
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer

10.1016/S0022-3476(88)80180-X J

"GlaxoSmithKline receives European Commission approval to market alli (orlistat 60mg)" (Press release)
